Concepts (51)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MAP Kinase Signaling System | 2 | 2022 | 320 | 0.320 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2022 | 12 | 0.200 |
Why?
|
| Pyrans | 1 | 2021 | 6 | 0.200 |
Why?
|
| src-Family Kinases | 1 | 2021 | 83 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2022 | 207 | 0.180 |
Why?
|
| Quinolines | 1 | 2021 | 96 | 0.180 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2021 | 525 | 0.170 |
Why?
|
| Dioxanes | 1 | 2019 | 4 | 0.170 |
Why?
|
| Biosensing Techniques | 1 | 2019 | 50 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 111 | 0.160 |
Why?
|
| Thiazoles | 1 | 2019 | 96 | 0.160 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 145 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 874 | 0.140 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 1403 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 1022 | 0.130 |
Why?
|
| Melanoma | 1 | 2019 | 836 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1680 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2480 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 3302 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2021 | 746 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2022 | 1615 | 0.070 |
Why?
|
| Carbohydrates | 1 | 2022 | 33 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 132 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 96 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2022 | 142 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2021 | 286 | 0.050 |
Why?
|
| Germ Cells | 1 | 2022 | 193 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2022 | 331 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 571 | 0.040 |
Why?
|
| Cell Extracts | 1 | 2019 | 11 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2019 | 312 | 0.040 |
Why?
|
| Cysteine | 1 | 2019 | 134 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2019 | 103 | 0.040 |
Why?
|
| Peptides | 1 | 2022 | 801 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 697 | 0.040 |
Why?
|
| Cell Movement | 1 | 2021 | 839 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 355 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1678 | 0.040 |
Why?
|
| Kinetics | 1 | 2019 | 1318 | 0.040 |
Why?
|
| Binding Sites | 1 | 2019 | 1298 | 0.030 |
Why?
|
| Proteomics | 1 | 2019 | 478 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 1740 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2022 | 1431 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 2316 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2022 | 3780 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2793 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 1795 | 0.030 |
Why?
|
| Animals | 2 | 2022 | 33898 | 0.020 |
Why?
|
| Humans | 4 | 2022 | 122412 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 4514 | 0.020 |
Why?
|
| Mice | 1 | 2022 | 17638 | 0.020 |
Why?
|